245 related articles for article (PubMed ID: 9427165)
1. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
[TBL] [Abstract][Full Text] [Related]
2. The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes.
Higaki S; Hasegawa Y; Morohashi M; Takayoshi Y
J Dermatol; 1995 Jan; 22(1):4-9. PubMed ID: 7897023
[TBL] [Abstract][Full Text] [Related]
3. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of Thai herbal extracts on acne involved microorganism.
Niyomkam P; Kaewbumrung S; Kaewnpparat S; Panichayupakaranant P
Pharm Biol; 2010 Apr; 48(4):375-80. PubMed ID: 20645714
[TBL] [Abstract][Full Text] [Related]
5. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
Nishijima S; Kurokawa I; Katoh N; Watanabe K
J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
[TBL] [Abstract][Full Text] [Related]
6. Activity of eleven kampo formulations and eight kampo crude drugs against Propionibacterium acnes isolated from acne patients: retrospective evaluation in 1990 and 1995.
Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
J Dermatol; 1996 Dec; 23(12):871-5. PubMed ID: 9037918
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis.
Li Z; Summanen PH; Downes J; Corbett K; Komoriya T; Henning SM; Kim J; Finegold SM
J Drugs Dermatol; 2015 Jun; 14(6):574-8. PubMed ID: 26091382
[TBL] [Abstract][Full Text] [Related]
8. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
10. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to.
Higaki S; Nakamura M; Morohashi M; Yamagishi T
Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499
[TBL] [Abstract][Full Text] [Related]
11. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.
Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
J Med Microbiol; 2014 May; 63(Pt 5):721-728. PubMed ID: 24523159
[TBL] [Abstract][Full Text] [Related]
14. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance of microbial strains isolated from Korean acne patients.
Moon SH; Roh HS; Kim YH; Kim JE; Ko JY; Ro YS
J Dermatol; 2012 Oct; 39(10):833-7. PubMed ID: 22779738
[TBL] [Abstract][Full Text] [Related]
16. Propionibacterium acnes Has Low Susceptibility to Chlorhexidine Digluconate.
Nakase K; Fukushima H; Yukawa T; Nakaminami H; Fujii T; Noguchi N
Surg Infect (Larchmt); 2018 Apr; 19(3):298-302. PubMed ID: 29447075
[TBL] [Abstract][Full Text] [Related]
17. In-vitro evaluation of marine derived fungi against Cutibacterium acnes.
Agrawal S; Adholeya A; Barrow CJ; Deshmukh SK
Anaerobe; 2018 Feb; 49():5-13. PubMed ID: 29100929
[TBL] [Abstract][Full Text] [Related]
18. Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.
Zhanel G; Critchley I; Lin LY; Alvandi N
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397052
[TBL] [Abstract][Full Text] [Related]
19. Hop Extract Acts as an Antioxidant with Antimicrobial Effects against
Weber N; Biehler K; Schwabe K; Haarhaus B; Quirin KW; Frank U; Schempp CM; Wölfle U
Molecules; 2019 Jan; 24(2):. PubMed ID: 30634461
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
Nakatsuji T; Kao MC; Fang JY; Zouboulis CC; Zhang L; Gallo RL; Huang CM
J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
